A mHealth app for sarcoidosis-associated fatigue: a feasibility randomized control trial
10.1016/j.rmed.2025.108490 · doi-reference
Design and rationale of a pilot randomized clinical trial investigating the use of a mHealth app for sarcoidosis-associated fatigue
10.1016/j.conctc.2023.101062 · doi-reference
Perceptions of the fatigue experience and a breathing awareness meditation-integrated mhelath app for fatigue and stress in patients with sarcoiidosis
10.1080/21641846.2022.2154499 · doi-reference
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial
10.1016/s2213-2600(22)00387-3 · doi-reference
Telehealth in sarcoidosis: a scoping review
10.1186/s12890-025-03528-w · doi-reference
Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial
10.1136/thoraxjnl-2021-216934 · doi-reference
Comparison of the effects of one-legged and two-legged exercise training on exercise capacity and fatigue in patients with sarcoidosis
10.1016/j.rmed.2025.108380 · doi-reference
High-intensity resistance training in newly diagnosed sarcoidosis- an exploratory study of effects on lung function, muscle strength, fatigue, dyspnea, health-related quality of life and lung immune cells
10.1080/20018525.2020.1730137 · doi-reference
Pulmonary rehabilitation in sarcoidosis: a systematic review and meta-analysis
10.1016/j.rmed.2023.107432 · doi-reference
Nutrition and corticosteroids in the treatment of sarcoidosis
10.1097/mcp.0000000000000501 · doi-reference
Feasibility of investigating methylphenidate for the treatment of sarcoidosis-associated fatigue (the FaST-MP study): a double-blind, parallel-arm randomised feasibility trial
10.1136/bmjresp-2020-000814 · doi-reference
Sarcoidosis: a state-of-the-art review
10.1183/13993003.01324-2025 · doi-reference
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
10.1016/s2213-2600(25)00338-8 · doi-reference
ERS clinical practice guidelines on treatment of sarcoidosis
10.1183/13993003.04079-2020 · doi-reference
The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review
10.1183/16000617.0057-2019 · doi-reference
Multidisciplinary strategies and new technologies in the management of sarcoidosis
10.1016/j.ejim.2025.106576 · doi-reference
Innovating care for people with sarcoidosis using a machine learning-driven approach
10.1186/s12931-025-03282-x · doi-reference
Quality of life and physical activity in 629 individuals with sarcoidosis: prospective, cross-sectional study using smartphones (Sarcoidosis App)
10.2196/38331 · doi-reference
First-line treatment of pulmonary sarcoidosis with prednisone or methotrexate
10.1056/nejmoa2501443 · doi-reference
Optimizing patient-reported outcomes for sarcoidosis
10.1016/j.coi.2025.102720 · doi-reference
Evaluating the minimal clinically important difference of the King's Sarcoidosis Questionnaire in a multicenter prospective study
10.1513/annalsats.202006-607oc · doi-reference
PROMs in sarcoidosis - what to use for systemic disease and individual organs and why?
10.1097/mcp.0000000000001203 · doi-reference
Health-related quality of life in sarcoidosis patients and the effect of occupational exposures: a cross-sectional study
10.1186/s12890-025-03552-w · doi-reference
Short-term particulate air pollution exposure is associated with increased severity of respiratory and quality of life symptoms in patients with fibrotic sarcoidosis
10.3390/ijerph15061077 · doi-reference
Uncovering sex and gender differences in sarcoidosis: a systematic review of current evidence
10.3390/jpm16010024 · doi-reference
Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire
10.1038/s41598-021-89383-1 · doi-reference
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden
10.1136/heartjnl-2021-319129 · doi-reference
The prevalence of obstructive sleep apnea in sarcoidosis and its impact on sleepiness, fatigue, and sleep-associated quality of life: a cross-sectional study with matched controls (the OSASA study)
10.5664/jcsm.10140 · doi-reference
